Literature DB >> 23633586

The structure of the caspase recruitment domain of BinCARD reveals that all three cysteines can be oxidized.

Kai En Chen1, Ayanthi A Richards, Tom T Caradoc-Davies, Parimala R Vajjhala, Gautier Robin, Linda H L Lua, Justine M Hill, Kate Schroder, Matthew J Sweet, Stuart Kellie, Bostjan Kobe, Jennifer Martin.   

Abstract

The caspase recruitment domain (CARD) is present in death-domain superfamily proteins involved in inflammation and apoptosis. BinCARD is named for its ability to interact with Bcl10 and inhibit downstream signalling. Human BinCARD is expressed as two isoforms that encode the same N-terminal CARD region but which differ considerably in their C-termini. Both isoforms are expressed in immune cells, although BinCARD-2 is much more highly expressed. Crystals of the CARD fold common to both had low symmetry (space group P1). Molecular replacement was unsuccessful in this low-symmetry space group and, as the construct contains no methionines, first one and then two residues were engineered to methionine for MAD phasing. The double-methionine variant was produced as a selenomethionine derivative, which was crystallized and the structure was solved using data measured at two wavelengths. The crystal structures of the native and selenomethionine double mutant were refined to high resolution (1.58 and 1.40 Å resolution, respectively), revealing the presence of a cis-peptide bond between Tyr39 and Pro40. Unexpectedly, the native crystal structure revealed that all three cysteines were oxidized. The mitochondrial localization of BinCARD-2 and the susceptibility of its CARD region to redox modification points to the intriguing possibility of a redox-regulatory role.

Entities:  

Keywords:  CARD proteins; alternative splicing; cysteine modification; methionine mutation for MAD phasing; mitochondrial localization

Mesh:

Substances:

Year:  2013        PMID: 23633586     DOI: 10.1107/S0907444913001558

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  6 in total

1.  Structure of the caspase-recruitment domain from a zebrafish guanylate-binding protein.

Authors:  Tengchuan Jin; Mo Huang; Patrick Smith; Jiansheng Jiang; T Sam Xiao
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-07-27

2.  CARD19, the protein formerly known as BinCARD, is a mitochondrial protein that does not regulate Bcl10-dependent NF-κB activation after TCR engagement.

Authors:  Kariana E Rios; Anuj K Kashyap; Sean K Maynard; Michael Washington; Suman Paul; Brian C Schaefer
Journal:  Cell Immunol       Date:  2020-07-29       Impact factor: 4.868

3.  Crystal structure of caspase recruiting domain (CARD) of apoptosis repressor with CARD (ARC) and its implication in inhibition of apoptosis.

Authors:  Tae-ho Jang; Seong Hyun Kim; Jae-Hee Jeong; Sunghwan Kim; Yeon-Gil Kim; Yeun Gil Kim; Hyun Ho Park
Journal:  Sci Rep       Date:  2015-06-03       Impact factor: 4.379

4.  CARD19 Interacts with Mitochondrial Contact Site and Cristae Organizing System Constituent Proteins and Regulates Cristae Morphology.

Authors:  Kariana E Rios; Ming Zhou; Nathaniel M Lott; Chelsi R Beauregard; Dennis P McDaniel; Thomas P Conrads; Brian C Schaefer
Journal:  Cells       Date:  2022-03-31       Impact factor: 7.666

5.  Influenza A virus use of BinCARD1 to facilitate the binding of viral NP to importin α7 is counteracted by TBK1-p62 axis-mediated autophagy.

Authors:  Xuyuan Wang; Li Jiang; Guangwen Wang; Wenjun Shi; Yuzhen Hu; Bo Wang; Xianying Zeng; Guobin Tian; Guohua Deng; Jianzhong Shi; Liling Liu; Chengjun Li; Hualan Chen
Journal:  Cell Mol Immunol       Date:  2022-09-02       Impact factor: 22.096

6.  Inflammasome Priming Mediated via Toll-Like Receptors 2 and 4, Induces Th1-Like Regulatory T Cells in De Novo Autoimmune Hepatitis.

Authors:  Adam S Arterbery; Jie Yao; Andrew Ling; Yaron Avitzur; Mercedes Martinez; Steven Lobritto; Yanhong Deng; Gan Geliang; Sameet Mehta; Guilin Wang; James Knight; Udeme D Ekong
Journal:  Front Immunol       Date:  2018-07-19       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.